Cencora Inc (BSP:C1CO34)
R$ 717.12 0 (0%) Market Cap: 277.21 Bil Enterprise Value: 285.61 Bil PE Ratio: 33.25 PB Ratio: 75.37 GF Score: 85/100

AmerisourceBergen Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 09:00PM GMT
Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

All right. Good afternoon, everybody. Welcome to the AmerisourceBergen session. I'm Bob Jones. I cover the health care supply chain here at Goldman Sachs, very excited to introduce AmerisourceBergen, as you know, a leading drug wholesaler and much more in the U.S. and globally. I'm joined by Steve Collis, Chairman, President and CEO of AmerisourceBergen; and Jim Cleary, EVP and CFO.

I think by this point, everyone knows the format. If you have a question, raise your hand. We'll get you a microphone. But otherwise, I think we're just going to jump right into Q&A.

Questions & Answers

Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

Steve, I think one of the biggest focuses for the industry quite frankly for the last several years but I think really coming out of this past quarter has been around, has the core pharma business stabilized and is, in fact, EBIT at the core level? I know there's always a lot of moving pieces. But just organically at the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot